World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
75
Citations
23750
World Ranking
1968
National Ranking
51

Overview

Jeffrey B. Ulmer is affiliated with Novartis in Switzerland and contributes extensively to scientific research in the fields of Medicine and Biochemistry, Genetics, and Molecular Biology. Their work spans several subfields, including Infectious Diseases, Molecular Biology, Epidemiology, Neurology, and Immunology.

The research topics that Jeffrey B. Ulmer has contributed to focus mainly on viral infections and vaccine technology. These topics include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Viral gastroenteritis research and epidemiology
  • RNA Interference and Gene Delivery
  • Long-Term Effects of COVID-19
  • Vaccines and immunoinformatics approaches
  • Respiratory viral infections research

Ulmer's recent publications highlight involvement in vaccine development and pandemic prevention. Notable recent papers include:

  • "Stopping pandemics before they start: Lessons learned from SARS-CoV-2," 2022, published in Science
  • "Development of a potent Zika virus vaccine using self-amplifying messenger RNA," 2020, published in Science Advances
  • "A self-amplifying mRNA SARS-CoV-2 vaccine candidate induces safe and robust protective immunity in preclinical models," 2022, published in Molecular Therapy
  • "Self-amplifying mRNA-Based Vaccine Technology and Its Mode of Action," 2021, published in Current topics in microbiology and immunology
  • "Antibody-guided structure-based vaccines," 2020, published in Seminars in Immunology

Frequent collaborators with whom Ulmer has co-authored multiple papers include Lbachir BenMohamed, Swayam Prakash, Hawa Vahed, Daniel Gil, and Nisha R. Dhanushkodi.

Many of Ulmer's research articles have been published in prominent venues such as bioRxiv (Cold Spring Harbor Laboratory), hosting six of their works, as well as Frontiers in Immunology, Science, Science Advances, and Molecular Therapy.

Best Publications

  • Heterologous protection against influenza by injection of DNA encoding a viral protein

    Jeffrey B. Ulmer;John J. Donnelly;Suezanne E. Parker;Gary H. Rhodes

  • Increased DNA vaccine delivery and immunogenicity by electroporation in vivo.

    Georg Widera;Melissa Austin;Dietmar Rabussay;Cheryl Goldbeck

  • Immunogenicity and protective efficacy of a tuberculosis DNA vaccine

    Huygen K;Denis O;Montgomery Dl

  • Targeting the innate immune response with improved vaccine adjuvants

    Achal Pashine;Nicholas M Valiante;Jeffrey B Ulmer

  • Nonviral delivery of self-amplifying RNA vaccines

    Andrew J. Geall;Ayush Verma;Gillis R. Otten;Christine A. Shaw

  • mRNA as a Transformative Technology for Vaccine Development to Control Infectious Diseases.

    Giulietta Maruggi;Cuiling Zhang;Junwei Li;Jeffrey B. Ulmer

  • Vaccine manufacturing: challenges and solutions

    Jeffrey B Ulmer;Ulrich Valley;Rino Rappuoli

  • Preclinical efficacy of a prototype DNA vaccine: Enhanced protection against antigenic drift in influenza virus

    John J. Donnelly;Arthur Friedman;Douglas Martinez;Donna L. Montgomery

  • Distribution of DNA vaccines determines their immunogenicity after intramuscular injection in mice.

    Marc Dupuis;Kimberly Denis-Mize;Carolyn Woo;Cheryl Goldbeck

  • Priming of cytotoxic T lymphocytes by DNA vaccines: requirement for professional antigen presenting cells and evidence for antigen transfer from myocytes.

    T.-M. Fu;J. B. Ulmer;M. J. Caulfield;R. R. Deck

  • Polynucleotide tuberculosis vaccine

    Kris Huygen;Margaret A. Liu;Donna Montgomery

  • Heterologous and Homologous Protection Against Influenza A by DNA Vaccination: Optimization of DNA Vectors

    Donna L. Montgomery;John W. Shiver;Karen R. Leander;Helen C. Perry

  • Evaluation of New Vaccines in the Mouse and Guinea Pig Model of Tuberculosis

    Susan L. Baldwin;Celine D’Souza;Alan D. Roberts;Brian P. Kelly

  • Generation of MHC class I-restricted cytotoxic T lymphocytes by expression of a viral protein in muscle cells: antigen presentation by non-muscle cells.

    J. B. Ulmer;R. R. Deck;C. M. Dewitt;J. J. Donnelly

  • PROTECTIVE CD4+ AND CD8+ T CELLS AGAINST INFLUENZA VIRUS INDUCED BY VACCINATION WITH NUCLEOPROTEIN DNA

    Jeffrey B. Ulmer;Tong-Ming Fu;R. Randall Deck;Arthur Friedman

  • The Ability of an Oligomeric Human Immunodeficiency Virus Type 1 (HIV-1) Envelope Antigen To Elicit Neutralizing Antibodies against Primary HIV-1 Isolates Is Improved following Partial Deletion of the Second Hypervariable Region

    S. W. Barnett;S. Lu;I. Srivastava;S. Cherpelis

  • A Cationic Nanoemulsion for the Delivery of Next-generation RNA Vaccines

    Luis A Brito;Michelle Chan;Christine A Shaw;Armin Hekele

  • Immunization of non-human primates with DNA vaccines

    Margaret A. Liu;William McClements;Jeffrey B. Ulmer;John Shiver

  • Human clinical trials of plasmid DNA vaccines.

    Margaret A Liu;Jeffrey B Ulmer

  • Mechanism of action of mRNA-based vaccines

    Carlo Iavarone;Derek T. O’hagan;Dong Yu;Nicolas F. Delahaye

  • Vaccination with Plasmid DNA Encoding Mycobacterial Antigen 85A Stimulates a CD4+ and CD8+ T-Cell Epitopic Repertoire Broader than That Stimulated by Mycobacterium tuberculosis H37Rv Infection

    Olivier Denis;Audrey Tanghe;Kamiel Palfliet;Fabienne Jurion

Frequent Co-Authors

John J. Donnelly
John J. Donnelly Novartis (United States)
Margaret A. Liu
Margaret A. Liu Karolinska Institute
John W. Shiver
John W. Shiver United States Military Academy
Susan W. Barnett
Susan W. Barnett Bill & Melinda Gates Foundation
Kris Huygen
Kris Huygen Institut Pasteur
Derek O'hagan
Derek O'hagan GlaxoSmithKline (United Kingdom)
Manmohan Singh
Manmohan Singh Beam Therapeutics
Rino Rappuoli
Rino Rappuoli Imperial College London
Nicholas M. Valiante
Nicholas M. Valiante Novartis (Switzerland)
Christian W. Mandl
Christian W. Mandl Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in complementing their studies in Immunology with practical healthcare roles, exploring related nursing programs can be beneficial. Many students seek "easy LPN programs to get into" as a stepping stone toward advanced nursing careers. These programs offer accessible entry points for gaining essential clinical skills.

Advancing from LPN to Nurse Practitioner is a common pathway, and selecting "which nurse practitioner program is easiest" can help streamline your educational journey without compromising quality. This approach allows students to efficiently build expertise in patient care, including immunological aspects.

For specialized mental health care, "best PMHNP programs" provide comprehensive training that combines clinical practice with psychiatric nursing, often including strong immunology components related to neuroinflammation and immune responses in mental health.

Budget-conscious students may consider "cheap psych NP programs," which offer affordable options without sacrificing program quality or clinical placement opportunities. These degrees position graduates for diverse career opportunities, including psychiatric nursing and immunology-related research.

Best Scientists Citing Jeffrey B. Ulmer

Trending Scientists